Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery.

OBJECTIVE To test the hypothesis that low serum antiendotoxin core antibody (EndoCAb) level is an independent predictor of adverse outcome following cardiac surgery. DESIGN Prospective, blinded, cohort study. SETTING Tertiary care medical center. SUBJECTS A total of 301 patients undergoing coronary artery bypass graft surgery and/or valvular heart surgery. DESIGN Preoperative serum was assayed for IgM EndoCAb, IgG EndoCAb, total IgM, and total IgG levels. Known preoperative risk factors were assessed, and patients were assigned a risk score using a validated method. MAIN OUTCOME MEASURE A major complication, defined as either in-hospital death or postoperative length of stay greater than 10 days. RESULTS Overall, a major complication occurred in 34 patients (11.3%). Lower IgM EndoCAb level independently predicted (P=.002) increased risk of major complication over and above the effects of preoperative risk score (P=.02), total IgG level (P=.07), and all other known perioperative risk factors. In contrast, IgG Endo-CAb and total IgM concentrations did not predict outcome. No association existed between risk score and level of IgM EndoCAb. CONCLUSION There is marked preoperative variability in humoral immunity against endotoxin core, which is not accounted for by differences in known preoperative risk factors. In this study, low levels of IgMEndoCAb were an important independent predictor of adverse postoperative outcome, which supports the theory that endotoxemia is a cause of postoperative morbidity.

[1]  J. Bion,et al.  Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. , 1996, JAMA.

[2]  I. Poxton.  Antibodies to lipopolysaccharide. , 1995, Journal of immunological methods.

[3]  G. Ramsay,et al.  Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. , 1995, JAMA.

[4]  J. Tu,et al.  Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. , 1995, Circulation.

[5]  Fink Mp.  Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability. , 1994 .

[6]  M. Onoe,et al.  A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. , 1994, The Journal of thoracic and cardiovascular surgery.

[7]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[8]  E L Hannan,et al.  Improving the outcomes of coronary artery bypass surgery in New York State. , 1994, JAMA.

[9]  J. Bion,et al.  Selective decontamination of the digestive tract reduces Gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation , 1994, Critical care medicine.

[10]  P. Merino,et al.  Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? , 1993, Critical care medicine.

[11]  R. Winchurch,et al.  Translocation. Incidental phenomenon or true pathology? , 1993, Annals of surgery.

[12]  D. Alling,et al.  A controlled trial of HA-1A in a canine model of gram-negative septic shock. , 1993, JAMA.

[13]  J. Cavaillon,et al.  Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide , 1993, The Journal of experimental medicine.

[14]  N. Koles,et al.  Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry. , 1992, The Journal of infectious diseases.

[15]  J. Wennberg,et al.  Multivariate Prediction of In‐Hospital Mortality Associated With Coronary Artery Bypass Graft Surgery , 1992 .

[16]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[17]  G. Beck,et al.  Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. , 1992, JAMA.

[18]  J. Baumgartner.  Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal. , 1991, Infectious disease clinics of North America.

[19]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[20]  M. Matteson,et al.  Sepsis after coronary bypass grafting: evidence for loss of the gut mucosal barrier. , 1991, The Annals of thoracic surgery.

[21]  Jerome J. Schentag,et al.  A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis , 1991 .

[22]  P. Parsons,et al.  Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. , 1991, The Journal of trauma.

[23]  C. Sprung,et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. , 1991 .

[24]  M. Fink,et al.  Increased intestinal permeability in endotoxic pigs. Mesenteric hypoperfusion as an etiologic factor. , 1991, Archives of surgery.

[25]  E. Deitch,et al.  Bacterial translocation of the gut flora. , 1990, The Journal of trauma.

[26]  F. Grover,et al.  Identification of patients at greatest risk for developing major complications at cardiac surgery. , 1990, Circulation.

[27]  R. Berg,et al.  Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. , 1990, Critical care medicine.

[28]  J. Kovacs,et al.  The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.

[29]  J. Harvey,et al.  Antibody to endotoxin is associated with decreased frequency of postoperative infection , 1989 .

[30]  A. Bernstein,et al.  A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.

[31]  L. Moldawer,et al.  Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. , 1989, Journal of immunology.

[32]  C. Natanson,et al.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock , 1989, The Journal of experimental medicine.

[33]  R. Demling,et al.  Posttraumatic multisystem organ failure. , 1988, JAMA.

[34]  A. Cerami,et al.  Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.

[35]  G. Machiedo,et al.  Endotoxemia and Bacteremia During Hemorrhagic Shock The Link Between Trauma and Sepsis? , 1988, Annals of surgery.

[36]  R. Berg,et al.  Bacterial translocation from the gut: a mechanism of infection. , 1987, The Journal of burn care & rehabilitation.

[37]  G. Barclay,et al.  Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies , 1987, Infection and immunity.

[38]  S. Gaffin,et al.  Endotoxemia associated with cardiopulmonary bypass. , 1987, The Journal of thoracic and cardiovascular surgery.

[39]  R. Freeman,et al.  Prevention of fever and gram negative infection after open heart surgery by antiendotoxin. , 1985, Thorax.

[40]  R. Goris,et al.  Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.

[41]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[42]  J. Whicher,et al.  AN Evaluation of the Hyland Laser Nephelometer PDQ System for the Measurement of Immunoglobulins , 1978, Annals of clinical biochemistry.

[43]  D. Morrison,et al.  DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS) , 1974, The Journal of experimental medicine.

[44]  R. Danner,et al.  Endotoxemia in human septic shock. , 1991, Chest.

[45]  L. W. Andersen,et al.  Presence of circulating endotoxins during cardiac operations. , 1987, The Journal of thoracic and cardiovascular surgery.

[46]  D. C. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[47]  O. Westphal,et al.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. , 1966, Bacteriological reviews.